Pharma Journalist - Page 118 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

FDA Grants ImmunityBio Approval to Supply Recombinant BCG (rBCG) Amid TICE BCG Shortage

Rznomics Inc. Liver Cancer Drug Receives Fast Track Designation

FDA Accepts Dupixent sBLA for Bullous Pemphigoid Treatment under Priority Review

FDA Accepts Gilead’s NDA for Twice-Yearly Lenacapavir for HIV Prevention

Biogen and Stoke Therapeutics Partner to Develop Zorevunersen for Dravet Syndrome Treatment

FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab for Sézary Syndrome

FDA Grants Full Approval of Deciphera’s ROMVIMZA for TGCT Treatment

FDA Approves GSK’s Penmenvy 5-in-1 Meningococcal Vaccine for MenABCWY Protection

QIAGEN Expands Bioinformatics Leadership with New Data Center in Australia/APAC

Newleos Therapeutics Raises $93.5M in Oversubscribed Series A to Advance Neuropsychiatric Disorder Treatments